Azor and Trilipix drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Trilipix (choline fenofibrate). Common drug interactions include anaemia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Azor and Trilipix. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.
What is Azor?
Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.
What is Trilipix?
Trilipix has active ingredients of choline fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 5,915 Trilipix users. Check the latest studies of Trilipix.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
34 people who take Azor and Trilipix together, and have interactions are studied.

What are the common drug interactions of Azor and Trilipix, by gender? *:
female:
- Anaemia (lack of blood)
- Chronic kidney disease
- Renal impairment (severely reduced kidney function)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Flushing (the warm, red condition of human skin)
- Abdominal pain
- Abdominal pain upper
- Back pain
- Bladder cancer
- Blood creatinine increased
male:
- Chronic kidney disease
- Pain in extremity
- Erythema (redness of the skin)
- Flushing (the warm, red condition of human skin)
- Gout (uric acid crystals building up in the body)
- Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
- Lethargy (tiredness)
- Limb injury
- Loss of consciousness
- Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
What are the common drug interactions of Azor and Trilipix, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Gout (uric acid crystals building up in the body)
50-59:
- Pain in extremity
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Chronic kidney disease
- Intraductal papillary mucinous neoplasm (tumour (neoplasm) that grows within the pancreatic ducts)
- Muscular weakness (muscle weakness)
- Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
- Myalgia (muscle pain)
- Pancreatitis acute (sudden inflammation of pancreas)
- Renal failure (kidney dysfunction)
60+:
- Chronic kidney disease
- Anaemia (lack of blood)
- Back pain
- Bladder cancer
- Blood creatinine increased
- Blood pressure diastolic decreased
- Blood urea increased
- Cardiac failure congestive
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Cystitis (inflammation of the wall of the bladder)
What are the existing conditions these people have? *
- Cardiac Disorder: 6 people, 17.65%
- Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 11.76%
- High Density Lipoprotein Decreased: 3 people, 8.82%
- Gout (uric acid crystals building up in the body): 3 people, 8.82%
- Depression: 3 people, 8.82%
- Pain: 2 people, 5.88%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Azor and Trilipix?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Azor and Trilipix:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Azor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Trilipix:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Azor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Trilipix and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil and choline fenofibrate (the active ingredients of Azor and Trilipix, respectively), and Azor and Trilipix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aricept cause Hearing Loss? - a second ago
- Zocor vs. Mevacor, side effect and effectiveness comparison - 4 seconds ago
- Mevacor vs. Pravachol, side effect and effectiveness comparison - 15 seconds ago
- Drug interactions of Candesartan Cilexetil and Mirtazapine - 15 seconds ago
- Could Faslodex cause Azotaemia? - 20 seconds ago
- Could Sotret cause Abdominal Adhesions? - 20 seconds ago
- Could Jakafi cause Cyst? - 20 seconds ago
- Could Lantus cause Dysgraphia? - 21 seconds ago
- Could Noroxin cause Agranulocytosis? - 24 seconds ago
- Could Norflex cause Paranoia? - 35 seconds ago